annamycin has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Booser, DJ; Esparza-Guerra, L; Esteva, FJ; Hortobagyi, GN; Priebe, W; Rivera, E; Valero, V | 1 |
| Ling, YH; Perez-Soler, R; Priebe, W; Van, NT; Zou, Y | 1 |
1 trial(s) available for annamycin and Lung Neoplasms
| Article | Year |
|---|---|
Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Doxorubicin; Drug Carriers; Drug Resistance, Neoplasm; Female; Humans; Infusions, Intravenous; Liposomes; Lung Neoplasms; Maximum Tolerated Dose; Middle Aged | 2002 |
1 other study(ies) available for annamycin and Lung Neoplasms
| Article | Year |
|---|---|
Antitumor activity of free and liposome-entrapped annamycin, a lipophilic anthracycline antibiotic with non-cross-resistance properties.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Chemical Phenomena; Chemistry, Physical; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; KB Cells; Leukemia P388; Liposomes; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Phenotype; Tumor Cells, Cultured | 1994 |